CRISPR screen in cancer: status quo and future perspectives.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

27 citing papers in PubMed, 33 citations in OpenAlex.

1. High-Content CRISPR Screening: Methods and Applications.MedComm · 2026
   Review
2. Patient-Derived Organoid-Based CRISPR Screens in Cancer Research: Applications, Advances, and Challenges.Cancer medicine · 2026
   Review
3. A Comprehensive Review on CRISPR-Based Screening and Its Applications.Molecular biotechnology · 2026
   Review
4. Cutting-edge advances in endocrine therapy for breast cancer (Review).Oncology letters · 2026
   Review
5. Emerging CRISPR Approaches for Countering Immune Evasion: Insight from Recent Studies.International journal of molecular sciences · 2026
   Review
6. CRISPR-Cas9 screen reveals that inhibition of enhancer of zeste homolog 2 sensitizes malignant T cells to dimethyl-fumarate-induced cell death.The FEBS journal · 2026
   Article
7. Integrating CRISPR/Cas technology with clinical trials: Principles, progress and challenges.Asian journal of pharmaceutical sciences · 2025
   Review
8. Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens.Cellular oncology (Dordrecht, Netherlands) · 2025
   Review
9. CRISPR/Cas technologies in pancreatic cancer research and therapeutics: recent advances and future outlook.Discover oncology · 2025
   Review
10. CRISPR screening approaches in breast cancer research.Cancer metastasis reviews · 2025
    Review
11. Brain Tumor Stem Cells: New Perspectives.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
12. Let's make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment.Cell biology and toxicology · 2024
    Review
13. Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review.Cureus · 2024
    Article
14. CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy.Experimental hematology & oncology · 2023
    Review
15. In vivo CRISPR/Cas9 screening identifies Pbrm1 as a regulator of myeloid leukemia development in mice.Blood advances · 2023
    Article
16. A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment.Functional & integrative genomics · 2023
    Review
17. Applying CRISPR-Cas9 screens to dissect hematological malignancies.Blood advances · 2023
    Review
18. Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy.Molecular cancer · 2023
    Review
19. A CRISPR screen in intestinal epithelial cells identifies novel factors for polarity and apical transport.eLife · 2023
    Article
20. Forward Genetic Screens as Tools to Investigate Role and Mechanisms of EMT in Cancer.Cancers · 2022
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

7 authors at 3 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as